Medico Remedies Ltd (MEDICO) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1002925, "name": "Medico Remedies", "stock_name": "Medico Remedies", "full_name": "Medico Remedies Ltd", "name_url": "stocks-analysis/medico-remedies", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "40.35", "chg": 1.25, "chgp": "3.2%", "dir": 1, "prev_price": "39.10", "mcapval": "319.00 Cr", "mcap": "Micro Cap", "scripcode": 540937, "symbol": "MEDICO", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "", "isin": "INE630Y01024", "curr_date": "Mar 13", "curr_time": "", "bse_nse_vol": "3.81 lacs", "exc_status": "Active", "traded_date": "Mar 13, 2026", "traded_date_str": "2026 03 13", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/medico-remedies-1002925-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Medico Remedies Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-ltd-is-rated-hold-3882691", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MedicoRemediesL_mojoScore_3882691.png", "date": "2026-03-10 10:10:02", "description": "Medico Remedies Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 30 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing." }, { "title": "Medico Remedies Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-ltd-is-rated-hold-3857882", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MedicoRemediesL_mojoScore_3857882.png", "date": "2026-02-26 10:10:03", "description": "Medico Remedies Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 30 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 February 2026, providing investors with an up-to-date view of the company’s performance and outlook." }, { "title": "Medico Remedies Ltd Valuation Shifts to Fair Amidst Market Pressure", "link": "https://www.marketsmojo.com/news/stocks-in-action/medico-remedies-ltd-valuation-shifts-to-fair-amidst-market-pressure-3854607", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MedicoRemediesL_valuationdot_3854607.png", "date": "2026-02-25 08:01:04", "description": "Medico Remedies Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade, reflecting evolving investor perceptions amid a challenging market backdrop. This recalibration in price-to-earnings and price-to-book ratios, alongside peer comparisons, offers fresh insights into the stock’s price attractiveness and potential investment appeal." }, { "title": "Medico Remedies Ltd Valuation Shifts to Fair Amidst Market Pressure", "link": "https://www.marketsmojo.com/news/stocks-in-action/medico-remedies-ltd-valuation-shifts-to-fair-amidst-market-pressure-3846291", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MedicoRemediesL_valuationdot_3846291.png", "date": "2026-02-19 08:02:00", "description": "Medico Remedies Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has recently undergone a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. This change reflects evolving market perceptions amid fluctuating price-to-earnings (P/E) and price-to-book value (P/BV) ratios, alongside comparative analysis with industry peers. Investors and analysts alike are reassessing the stock’s price attractiveness in light of these developments." }, { "title": "Medico Remedies Declines 0.61%: Valuation Shift and Q3 Results Shape Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/medico-remedies-declines-061-valuation-shift-and-q3-results-shape-week-3839345", "imagepath": "", "date": "2026-02-14 12:00:11", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Feb 9:</strong> Stock opens strong at Rs.48.58, up 2.04%</p>\n <p><strong>Feb 10:</strong> Continued gains to Rs.49.59 (+2.08%) amid positive sentiment</p>\n <p><strong>Feb 11:</strong> Sharp reversal with a 2.44% drop to Rs.48.38</p>\n <p><strong>Feb 13:</strong> Q3 results reveal strong revenue growth but margin pressure; valuation shifts to fair</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.47.61</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div c..." }, { "title": "Medico Remedies Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-ltd-is-rated-hold-3839194", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MedicoRemediesL_mojoScore_3839194.png", "date": "2026-02-14 10:10:05", "description": "Medico Remedies Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 30 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 February 2026, providing investors with an up-to-date perspective on the company’s performance and outlook." }, { "title": "Are Medico Remedies Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-medico-remedies-ltd-latest-results-good-or-bad-3838510", "imagepath": "", "date": "2026-02-13 20:28:06", "description": "Medico Remedies Ltd's latest financial results for the quarter ending December 2025 reflect a complex operational landscape characterized by significant revenue growth alongside challenges in profitability. The company reported net sales of ₹58.68 crores, which represents a year-on-year growth of 48.59%, substantially outpacing the previous year's growth rate of 32.65%. This impressive revenue increase indicates a strong market presence and effective sales strategies within the competitive pharmaceutical sector.\n\nHowever, the profitability metrics tell a different story. The net profit for the same quarter was ₹2.87 crores, reflecting a modest year-on-year growth of 9.54%, a significant decline from the previous year's growth of 80.69%. This disparity between revenue and profit growth highlights a concerning trend of margin compression. The operating margin, excluding other income, decreased to 7.38% from 7..." }, { "title": "Medico Remedies Q3 FY26: Strong Revenue Surge Masks Margin Compression Concerns", "link": "https://www.marketsmojo.com/news/result-analysis/medico-remedies-q3-fy26-strong-revenue-surge-masks-margin-compression-concerns-3837920", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MedicoRemedies_quaterlyResult_3837920.png", "date": "2026-02-13 10:15:32", "description": "Medico Remedies Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹390.02 crores, reported a robust top-line performance in Q3 FY26 with net sales surging 48.59% year-on-year to ₹58.68 crores. However, the quarter revealed a concerning trend in profitability metrics, with net profit at ₹2.87 crores showing sequential growth of 11.67% but masking deeper operational challenges. The stock has faced significant headwinds over the past year, declining 30.89% whilst trading at ₹47.00, approximately 35% below its 52-week high of ₹71.98." }, { "title": "Medico Remedies Ltd Valuation Shifts to Fair Amidst Market Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/medico-remedies-ltd-valuation-shifts-to-fair-amidst-market-volatility-3836563", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MedicoRemediesL_valuationdot_3836563.png", "date": "2026-02-13 08:02:52", "description": "Medico Remedies Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade as of late December 2025. This recalibration reflects evolving market perceptions amid fluctuating financial metrics and sector dynamics, prompting investors to reassess the stock’s price attractiveness relative to its historical averages and peer group." } ], "total": 169, "sid": "1002925", "stock_news_url": "https://www.marketsmojo.com/news/medico-remedies-1002925" }, "announcements": [ { "caption": "Clarification With Regards To Additional Details Sought In Respect Of Outcome Of Board Meeting Held On 18Th February 2026 Submitted To Exchange On 18Th February 2026", "datetime": "24-Feb-2026", "details": "Please find enclosed", "source": "BSE" }, { "caption": "Intimation Of Action Taken Or Order Passed By Regulatory Statutory Enforcement Authority Or Judicial Body Under Regulation 30 (Read With Part B Of Schedule III) (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)", "datetime": "24-Feb-2026", "details": "Please find enclosed", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Change in Management", "datetime": "18-Feb-2026", "details": "Please find enclosed", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Medico Remedies Ltd has announced <strong>2:10</strong> stock split, ex-date: 16 Mar 23", "dt": "2023-03-16", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Medico Remedies Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 16 Nov 21", "dt": "2021-11-16", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

Feb 9: Stock opens strong at Rs.48.58, up 2.04%

Feb 10: Continued gains to Rs.49.59 (+2.08%) amid positive sentiment

Feb 11: Sharp reversal with a 2.44% drop to Rs.48.38

Feb 13: Q3 results reveal strong revenue growth but margin pressure; valuation shifts to fair

Week Open

Rs.47.61

Week Close

Read full news article

Medico Remedies Ltd is Rated Hold

2026-02-14 10:10:05

Medico Remedies Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 30 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 February 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Are Medico Remedies Ltd latest results good or bad?

2026-02-13 20:28:06

Medico Remedies Ltd's latest financial results for the quarter ending December 2025 reflect a complex operational landscape characterized by significant revenue growth alongside challenges in profitability. The company reported net sales of ₹58.68 crores, which represents a year-on-year growth of 48.59%, substantially outpacing the previous year's growth rate of 32.65%. This impressive revenue increase indicates a strong market presence and effective sales strategies within the competitive pharmaceutical sector. However, the profitability metrics tell a different story. The net profit for the same quarter was ₹2.87 crores, reflecting a modest year-on-year growth of 9.54%, a significant decline from the previous year's growth of 80.69%. This disparity between revenue and profit growth highlights a concerning trend of margin compression. The operating margin, excluding other income, decreased to 7.38% from 7...

Read full news article

Medico Remedies Q3 FY26: Strong Revenue Surge Masks Margin Compression Concerns

2026-02-13 10:15:32

Medico Remedies Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹390.02 crores, reported a robust top-line performance in Q3 FY26 with net sales surging 48.59% year-on-year to ₹58.68 crores. However, the quarter revealed a concerning trend in profitability metrics, with net profit at ₹2.87 crores showing sequential growth of 11.67% but masking deeper operational challenges. The stock has faced significant headwinds over the past year, declining 30.89% whilst trading at ₹47.00, approximately 35% below its 52-week high of ₹71.98.

Read full news article

Medico Remedies Ltd Valuation Shifts to Fair Amidst Market Volatility

2026-02-13 08:02:52

Medico Remedies Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade as of late December 2025. This recalibration reflects evolving market perceptions amid fluctuating financial metrics and sector dynamics, prompting investors to reassess the stock’s price attractiveness relative to its historical averages and peer group.

Read full news article